• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ACUTUS MEDICAL, INC. ACQMAP 3D IMAGING AND MAPPING CATHETER; CATHETER, INTRACARDIAC MAPPING, HIGH-DENSITY ARRAY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ACUTUS MEDICAL, INC. ACQMAP 3D IMAGING AND MAPPING CATHETER; CATHETER, INTRACARDIAC MAPPING, HIGH-DENSITY ARRAY Back to Search Results
Model Number 900003
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Thromboembolism (2654); Pericardial Effusion (3271)
Event Date 01/11/2019
Event Type  Injury  
Event Description
On (b)(6) 2019 a biosense webster preface sheath was used to guide the abbott (b)(4) 71cm needle to the transseptal puncture site where a single transseptal puncture was performed.The acqguide sheath was then exchanged via a guidewire.The acqguide sheath and achieve guidewire were used to position the ablation catheter for pvi.The ablation catheter used was an arctic front balloon catheter.Isolation of the lupv and llpv was achieved without issue.There were some issues in gaining access to the rupv with the achieve guidewire.To allow greater reach within the acqguide sheath, the sleeve was cut off the ablation catheter providing access to successfully isolate both the rupv and rlpv.The ablation catheter was removed and the acqmap catheter was prepared per ifu.The acqmap was then inserted to the la via the acqguide sheath.Initial respiratory compensation and system set up was completed without issue.Using ultrasound, several attempts (approximately 3-4) were made to center the acqmap catheter in the la, but it proved difficult with the catheter sitting high and near the anterior roof and base of the laa.A single attempt was made to better center the acqmap catheter by pulling the catheter back into the acqguide sheath.The devices were pulled back to, but not through the transseptal puncture site.The acqmap catheter was then re-deployed.Ultimately it was decided to commence anatomy creation with the acqmap catheter near the anterior roof and base of the laa.It was not possible to move the acqmap catheter more centrally.The acqmap catheter was not in the appendage when it was placed anterior and superior.The amplitude signals on the acqmap catheter were relatively low indicating the acqmap catheter was in the la.It was noted that the acqmap catheter rotated easily during anatomy collection, indicating the catheter was not trapped in an enclosed space or touching the pericardium.After approximately 45s of anatomy collection, the patient's blood pressure dropped dramatically, and the patient became unresponsive with labored breathing.A trans-thoracic echo was performed immediately and confirmed a pericardial effusion.A pericardiocentesis kit was used to facilitate access to the pericardium and successfully removed approximately 600 milliliters of excess fluid from the pericardial space.Protamine was administered to reverse the effects of the anticoagulant.Surgical intervention was not necessary to resolve the effusion.The patient immediately recovered and was responsive with normal blood pressure.The patient's only complaint was discomfort in the chest as a result of the drain.The acqguide sheath and acqmap catheters were removed from the patient and the procedure was aborted.The patient's activated clotting time (act) was maintained at 350s post transseptal puncture.Act was unknown when the patient left the lab.It is unknown what, if any other medications were administered to the patient post procedure.Prior to the ablation procedure the patient's af therapy consisted of drug therapy, however it is unknown which drug therapy was used.It is unknown if the patient had any previous strokes.There were no difficulties experienced in deploying, collapsing, and withdrawing the acqmap catheter during the case.On (b)(6) 2019 acutus was informed that the patient suffered a stroke.Appropriate therapy was administered to treat the stroke and the patient made a full recovery.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACQMAP 3D IMAGING AND MAPPING CATHETER
Type of Device
CATHETER, INTRACARDIAC MAPPING, HIGH-DENSITY ARRAY
Manufacturer (Section D)
ACUTUS MEDICAL, INC.
2210 faraday avenue
suite 100
carlsbad CA 92008
Manufacturer (Section G)
ACUTUS MEDICAL, INC.
2210 faraday avenue
suite 100
carlsbad CA 92008
Manufacturer Contact
karen kincade
2210 faraday avenue
suite 100
carlsbad, CA 92008
4422326123
MDR Report Key11942587
MDR Text Key255621437
Report Number3012120746-2019-00001
Device Sequence Number1
Product Code MTD
UDI-Device Identifier00857042007029
UDI-Public(01)00857042007029(10)100177(17)200813
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
K170819
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Physician
Type of Report Initial
Report Date 02/14/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/04/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date08/13/2020
Device Model Number900003
Device Catalogue Number900003
Device Lot NumberLN100177
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/11/2019
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured08/13/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Life Threatening; Required Intervention;
Patient Age45 YR
Patient Weight78
-
-